| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.07 |